ClinicalTrials.Veeva

Menu

Efficacy and Safety of the Distal Radial Approach (TunDRA)

G

General Administration of Military Health, Tunisia

Status

Unknown

Conditions

Coronary Artery Disease
Vascular Access Complication

Treatments

Procedure: conventional radial artery approach
Procedure: distal radial artery approach

Study type

Interventional

Funder types

NETWORK

Identifiers

NCT05311111
santemilitaire7

Details and patient eligibility

About

The aim of this non-inferiority trial is to determine if the distal radial access (DRA) during percutaneous coronary intervention (PCI) has an acceptable efficacy compared to the reference access through the conventional radial artery (TRA) with a lower rate of radial artery occlusion (RAO) in real life practice.

Full description

The conventional radial approach is the recommended vascular access for percutaneous coronary interventions. It is effective, feasible, but associated with a risk of occlusion of the radial artery.

The distal radial approach is proposed as a new approach to reduce complications and preserve the radial artery. However, few clinical trials in real life were conducted in North African patients.

This trial aims to evaluate the efficacy and safety of the distal radial approach versus the conventional radial approach.

This trial is a non-inferiority, randomized controlled trial with two parallel arms: distal radial approach and conventional radial approach. Two hundred and fifty patients scheduled for percutaneous coronary intervention will be included. The two main endpoints are the puncture success rate with a non-inferiority margin of 10% and the rate of 30-day occlusion of the punctured radial artery.

Secondary endpoints: catheterization success, crossover rate, procedure time, radial artery spasm, bleeding complications, QuickDASH score, pain score and operator satisfaction A single blind analysis will be led according to the per-protocol and intention-to-treat methods.

Avoiding occlusion of the puncture site allows to preserve the radial artery for subsequent coronary or cerebral percutaneous interventions as well as for coronary bypasses and hemodialysis fistulas. The results will provide the parameters related to the efficacy and safety of the distal radial approach, so improving clinical practice.

Enrollment

250 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Over 18 years old.
  • Hospitalized in the cardiology department of the military hospital of Tunis.
  • elective Percutaneous coronary intervention performed by experienced operators or fellows trained in the proximal and distal radial approach

Non-inclusion criteria:

  • not provided written informed consent

  • both radial arteries were used for prior catheterization

  • Under oral anticoagulation

  • Having coronary bypass surgery

  • Hemodynamic instability

  • contra-indication to the radial approach:

    • Orthopedic surgery: amputation
    • Severe burns of both upper limbs.
    • Radial artery pulse not palpable, negative modified Allen test or Barbeau classification type D
    • Identified radial vascular anomaly: stenosis, fistula, tortuosity not allowing passage of the catheter

Exclusion criteria

  • death within a short period of time after admission
  • PCI by the same puncture site will be performed within 30 days after the first puncture
  • lost to follow-up

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

250 participants in 2 patient groups

distal radial artery approach
Experimental group
Description:
Elective percutaneous coronary intervention by forearm radial artery through the distal radial artery in the dorsum of the hand or the anatomical snuff-box
Treatment:
Procedure: distal radial artery approach
conventional radial artery approach
Active Comparator group
Description:
Elective percutaneous coronary intervention through conventional radial artery access
Treatment:
Procedure: conventional radial artery approach

Trial contacts and locations

1

Loading...

Central trial contact

Aymen Noamen, MD; Ahmed Ben Amara, fellow

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems